Leuprorelin Acetate Injection Kit 11.25 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuprorelin Acetate Injection Kit 11.25 mg, covering 2025-10-07 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"